Peter Colabuono - 21 May 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 May 2025, 13:50:43 UTC
Prior SEC filing
12 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bruce Steel, Attorney-in-Fact

Key filing fact

Peter Colabuono filed Form 4 for Equillium, Inc. (EQ) on 23 May 2025.

Key facts

  • This page summarizes Peter Colabuono's Form 4 filing for Equillium, Inc. (EQ).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 23 May 2025, 13:50.

Change

  • Previous filing in this sequence was filed on 12 Dec 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001819620 Primary reporting owner

Colabuono Peter

Relationship
Director
Address
C/O EQUILLIUM, INC., 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA
Signature
/s/ Bruce Steel, Attorney-in-Fact
Signature date
23 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQ transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
$0
Shares
+20,000
Change %
Price
$0.000000
Shares after
20,000
Date
21 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$0.3900
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in twelve equal monthly installments commencing on the grant date of May 21, 2025, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .